Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-14 Purchase | 2022-06-15 4:05 pm | Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/CSO | 30,000 | $0.62 | $18,600 | 34,500 (Direct) | View |
| 2021-04-26 Purchase | 2021-04-26 6:16 pm | Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. EVP, Chief Strategy Officer | 4,500 | $2.03 | $9,135 | 4,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-11 Option Award | 2022-08-04 4:16 pm | N/A 2032-07-11 | Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/CSO | 130,000 | $0 | 130,000 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 06:15 am | N/A 2031-12-08 | Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. President/ChiefStrategyOfficer | 300,000 | $0 | 304,500 (Direct) | View |
| 2020-12-07 Option Award | 2020-12-29 4:44 pm | N/A 2030-12-07 | Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. Executive VP, CSO | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-08-27 Option Award | 2020-08-28 2:01 pm | N/A 2030-08-27 | Qualigen Therapeutics Inc. | QLGN | BROIDRICK AMY S. Director | 50,000 | $0 | 50,000 (Direct) | View |